CHCI vs REAX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

CHCI

50.0
AI Score
VS
REAX Wins

REAX

55.8
AI Score

Investment Advisor Scores

CHCI

50score
Recommendation
HOLD

REAX

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CHCI REAX Winner
Forward P/E 12.9032 0 Tie
PEG Ratio 0.8061 0 Tie
Revenue Growth 74.1% 29.6% CHCI
Earnings Growth 500.0% 0.0% CHCI
Tradestie Score 50.0/100 55.8/100 REAX
Profit Margin 32.2% -0.7% CHCI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CHCI 1M: -10.8% · 3M: +10.7% REAX 1M: -16.7% · 3M: +402.1%

Current Technical Phase

CHCI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 37.5 · Price: $16.44

REAX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 37.0 · Price: $11.70

Fundamentals Snapshot

Metric CHCI REAX
Market Cap — —
Forward P/E 12.9 23.3
Trailing P/E 7.2 —
Revenue (TTM) — —
Revenue Growth 0.3% 0.3%
Gross Margin 0.3% 0.1%
Operating Margin 0.1% 0.0%
EPS 2.34 -3.35
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, REAX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.